Bio-Techne (TECH) reported fiscal Q1 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.41 a year earlier.
Analysts polled by Capital IQ expected $0.38.
Net sales for the quarter ended Sept. 30 were $289.5 million, up from $276.9 million a year earlier.
Analysts surveyed by Capital IQ expected $280.1 million.
Separately, the company maintained its quarterly dividend at $0.08 per share, payable Nov. 22 to shareholders of record on Nov. 11.
Shares of the company rose 4.6% in recent premarket activity.
Price: 73.99, Change: +3.25, Percent Change: +4.59
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。